Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989;77(1):21-37.
doi: 10.1007/BF01255816.

Dopamine and sexual behavior in the male rat: a reevaluation

Affiliations

Dopamine and sexual behavior in the male rat: a reevaluation

A Agmo et al. J Neural Transm. 1989.

Abstract

In castrated male rats treated with a low dose of testosterone propionate (0.40 mg/kg per week), the dopamine agonists amphetamine and amfonelic acid reduced mount latency without affecting other aspects of sexual behavior. Apomorphine, in doses between 0.05 and 0.15 mg/kg, and 1-DOPA 5-45 mg/kg + carbidopa 50 mg/kg, lacked effect on sexual behavior. Both amphetamine and amfonelic acid increased locomotor activity in a dose-dependent manner. Apomorphine, in the lowest dose, produced a reduction whereas the higher doses of this drug as well as all doses of 1-DOPA lacked effect on this behavior. In castrated animals implanted with a testosterone-filled Silastic capsule, showing a level of sexual activity indistinguishable from that of intact animals, amphetamine and amfonelic acid did not affect sexual behavior. The dopamine receptor antagonists haloperidol and cis(Z)-flupentixol reduced sexual behavior, whereas pimozide was without effect in the dose range used. The doses of haloperidol and flupentixol that were required to reduce sexual activity were such that they also affected motor execution measured in a treadmill test. It is suggested that increased dopaminergic neurotransmission may stimulate sexual behavior in an indirect way, augmenting behavioral arousal. The inhibitory effects of dopamine antagonists could be explained either by a reduced arousal level or by motor deficiencies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharm Pharmacol. 1976 Nov;28(11):855-7 - PubMed
    1. Life Sci. 1980 Aug 25;27(8):617-31 - PubMed
    1. J Physiol (Paris). 1957 Jan-Mar;49(1):381-5 - PubMed
    1. Pharmacol Biochem Behav. 1987 Sep;28(1):47-52 - PubMed
    1. Eur J Pharmacol. 1985 Jun 19;112(3):371-8 - PubMed

Publication types

LinkOut - more resources